The National Institutes of Health shared a post on LinkedIn:
“Dr. Anthony Letai was sworn in today as the new director of NIH’s National Cancer Institute.
Dr. Letai holds decades of experience studying cell death in cancer, identifying predictive biomarkers, and developing new treatments, including cellular immunotherapies.
Dr. Letai will oversee the nation’s premier cancer research agency which works to dramatically reduce the prevalence of cancer, a critical step in our quest to reduce chronic illness and Make America Healthy Again. Welcome, Dr. Letai!
More posts featuring NIH on OncoDaily.